FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Disqualify 2 Minnesota Researchers: Public Citizen

Public Citizen says FDA should disqualify from conducting clinical trials two doctors at the Hennepin County Medical Center and the centers institutio...

Marketing

Fast Track for AstraZeneca Lokelma Indication

FDA grants fast track designation to AstraZenecas hyperkalemia drug Lokelma to reduce arrhythmia-related cardiovascular outcomes in patients on chroni...

Human Drugs

Fast Track for Zentalis Uterine Carcinoma Drug

FDA grants fast track designation to a Zentalis investigative drug for uterine serous carcinoma.

Human Drugs

Alzheimers Treatment, Diagnostic Registry Launched

The Alzheimers Association and other stakeholders are launching a national registry for Alzheimers diagnostic and treatment information.

Human Drugs

Meeting the 510(j)(3) Reporting Requirement

Two Wiley Rein attorneys suggest ways companies could approach the new FDA section 510(j)(3) drug reporting requirement.

Human Drugs

SterRx Recalls 240 Drug Lots Over Sterility

SterRx recalls 240 lots of various drug products within their expiry period due to equipment and process issues that could lead to a lack of sterility...

Medical Devices

FDA Clears Pantheris for In-stent Restinosis

FDA clears an Avinger 510(k) for a new clinical indication for the Pantheris image-guided atherectomy system treating in-stent restenosis in the lowe...

Medical Devices

Changes for Electronic Submission Guidance

Cook Group recommends improvements to an FDA draft guidance on the electronic submission eSTAR template.

Medical Devices

Blackrock Neurotech Breakthrough Status for Brain Interface

FDA grants Blackrock Neurotech a breakthrough device designation for its MoveAgain Brain Computer Interface System that is intended to provide immobil...

Human Drugs

CytoDyn Resubmits Rolling BLA for HIV Therapy

CytoDyn begins resubmitting a rolling BLA for leronlimab, a CCR5 antagonist used in combination therapy with highly active antiretroviral therapy for ...